PXSLY Projected Dividend Yield

Pharmaxis Ltd ( OTCBB : PXSLY )

Pharmaxis is a pharmaceutical research company. Co.'s product pipeline includes Semicarbazide-Sensitive Amine Oxidase for Non-Alcoholic Steatohepatitis (NASH) and diabetic retinopathy; Lysyl Oxidase Like Inhibitors targeting fibrotic diseases including NASH, pulmonary fibrosis, kidney fibrosis and cardiac fibrosis; and Lysyl Oxidase Inhibitors targeting severe fibrotic indications including scarring and some cancers. Co.'s products include Bronchitol®, an inhaled dry powder for the treatment of cystic fibrosis and is marketed in Europe, Russia and Australia; and Aridol®, a lung function test for asthma and is approved and sold in the United States, Europe, Australia and Asia.

20 YEAR PERFORMANCE RESULTS